| TP53 Status as a Determinant of Pro-vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer (vol, 111, pg 1202, 2019) UK Mukhopadhyay, CC Oturkar, C Adams, N Wickramasekera, S Bansal, ... JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 115 (4), 482-482, 2023 | | 2023 |
| Gastrointestinal Cancers: Racial and Ethnicity Differences M Singh, S Konduri, S Datta, W Papenfuss, G Belini, A Chevinsky, ... | | 2021 |
| Abstract PS7-84: Lymphovascular invasion among female patients diagnosed with breast cancer M Singh, S Konduri, R Rovin Cancer Research 81 (4_Supplement), PS7-84-PS7-84, 2021 | | 2021 |
| Epidemiology of male breast cancer S Konduri, M Singh, G Bobustuc, R Rovin, A Kassam The Breast 54, 8-14, 2020 | 104 | 2020 |
| BIOM-04. BRAIN METASTASIS AMONG FEMALE PATIENTS DIAGNOSED WITH STAGE IV BREAST CANCER N Lamba, T Smith, B Iorgulescu Neuro-oncology, 2020 | | 2020 |
| Abstract P3-10-03: Exploiting p53-dependent functional duality of estrogen receptor-beta to repurpose tamoxifen for triple negative breast cancer therapy GM Das, UK Mukhopadhyay, CC Oturkar, C Adams, N Wickramasekera, ... Cancer Research 80 (4_Supplement), P3-10-03-P3-10-03, 2020 | | 2020 |
| Exploiting p53-dependent functional duality of estrogen receptor-beta to repurpose tamoxifen for triple negative breast cancer therapy GM Das, UK Mukhopadhyay, CC Oturkar, C Adams, N Wickramasekera, ... CANCER RESEARCH 80 (4), 2020 | | 2020 |
| Predictors of lymphovascular invasion among female patients diagnosed with breast cancer M Singh, S Konduri, GC Bobustuc, R Rovin | | 2020 |
| P53 level and MGMT promoter methylation are playing a role in Zika virus replication in glioblastoma SD Zwernik, B Adams, J Yin, S Konduri, R Rovin, P Akhtar Journal of Patient-Centered Research and Reviews, 2020 | | 2020 |
| Targeting MGMT to treat therapy resistant and metastatic melanoma growth S Konduri, D Bosenko, D Donohoe, M Singh, R Rovin, GC Bobustuc | | 2020 |
| Estrogen-mediated downregulation of CD24 in breast cancer cells (vol 123, pg 66, 2008) BA Kaipparettu, S Malik, SD Konduri, W Liu, M Rokavec, H van der Kuip, ... INTERNATIONAL JOURNAL OF CANCER 145 (10), E21-E21, 2019 | | 2019 |
| TP53 status as a determinant of pro-vs anti-tumorigenic effects of estrogen receptor-beta in breast cancer UK Mukhopadhyay, CC Oturkar, C Adams, N Wickramasekera, S Bansal, ... JNCI: Journal of the National Cancer Institute 111 (11), 1202-1215, 2019 | 46 | 2019 |
| MGMT inhibition is associated with MAPK pathway inhibition and enhances Raf, MEK, ERK inhibitors and restores meaningful Temozolomide activity in melanoma GC Bobustuc, AB Kassam, D Bosenko, DL Donohoe, RA Rovin, ... Cancer Research 79 (13_Supplement), 3052-3052, 2019 | | 2019 |
| Transglutaminase 2 (TGM2) overexpression contributes to triple-negative breast cancer metastasis through AFAP1-dependent pathway M Piacsek, A Sand, RA Rovin, D Bosenko, SD Konduri, JA Tjoe, J Yin Cancer Research 79 (13_Supplement), 168-168, 2019 | | 2019 |
| Abstract P1-08-35: Treatment across the four molecular types of breast cancer: Insight from the national cancer database, 2010–2014 (N= 827,888) SD Konduri, M Singh, GC Bobustuc, RA Rovin, AB Kassam Cancer Research 79 (4_Supplement), P1-08-35-P1-08-35, 2019 | | 2019 |
| Abstract P1-08-28: Impact of surgery and time to surgery on breast cancer survival in the United States, 2004–2014 (N= 2,211,245) M Singh, SD Konduri, GC Bobustuc, RA Rovin, AB Kassam Cancer Research 79 (4_Supplement), P1-08-28-P1-08-28, 2019 | | 2019 |
| CADD-50. AN OLD STORY (MGMT) IN AN EXPANDED CONTEXT (NATIONAL CANCER DATABASE) S Konduri, M Singh, R Rovin, G Bobustuc, A Kassam Neuro-Oncology 20 (Suppl 6), vi282, 2018 | | 2018 |
| MGMT inhibition in ER positive breast cancer leads to CDC2, TOP2A, AURKB, CDC20, KIF20A, Cyclin A2, Cyclin B2, Cyclin D1, ERα and Survivin inhibition and enhances response to … GC Bobustuc, AB Kassam, RA Rovin, S Jeudy, JS Smith, B Isley, M Singh, ... Oncotarget 9 (51), 29727, 2018 | 22 | 2018 |
| DSF-Cu complex sensitizes patient-derived unmethylated MGMT expressing brain tumor cells to temozolomide GC Bobustuc, AB Kassam, RA Rovin, D Donohoe, D Bosenko, ... Cancer Research 78 (13_Supplement), 4831-4831, 2018 | | 2018 |
| Abstract P3-10-17: Predictors of overall survival and disease-free survival for women diagnosed with invasive breast cancer: A large single-center study M Singh, SD Konduri, GC Bobustuc, RA Rovin Cancer Research 78 (4_Supplement), P3-10-17-P3-10-17, 2018 | | 2018 |
